Post-approval studies (Phase 4)Looking for participantsNCT06356012
What this trial is testing
Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod
Who this might be right for
HSIL, High-Grade Squamous Intraepithelial LesionsVaginal MicrobiomeBiomarkers
Barretos Cancer Hospital 96